Arquivamento definitivo - Art. 33 da LPI
#11.1.1
07/22/2025
RPI 2846
Application data
Number
112023022493Type
Filing
Publication
PCT
US2022026516 The application was abandoned: examination was not requested within the 36 months following the 04/27/2022 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 07/22/2025. We update with every new RPI gazette, published weekly.
Applicants
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
US
Inventors
D. H. (pessoa física)
US
M. N. (pessoa física)
US
Y. H. (pessoa física)
US
IPC Classification
Priority claims
US
63/181,138 · 04/28/2021
Abstract
ANTICORPOS PARA TRATAMENTO E PREVENÇÃO DE COVID-19 E VARIANTES EMERGENTES. A presente invenção refere-se a uma proteína spike (S) recombinante da variante B.1.351.2-7 do vírus SARS-CoV-2, a sequências de nucleotídeo de DNA e RNA codificando a proteína spike recombinante de B.1.351.2-7 e anticorpos engenheirados que se ligam à proteína spike de B.1.351.2-7 e neutraliza o vírus B.1.351.2-7.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
07/22/2025
RPI 2846
#11.1
05/06/2025
RPI 2835
#1.3
02/15/2024
RPI 2771
#1.5
01/16/2024
RPI 2767
#1.1
11/07/2023
RPI 2757
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.